Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Non-Current Deffered Revenue (2016 - 2022)

Historic Non-Current Deffered Revenue for Veracyte (VCYT) over the last 10 years, with Q1 2022 value amounting to $278000.0.

  • Veracyte's Non-Current Deffered Revenue fell 6278.45% to $278000.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $278000.0, marking a year-over-year decrease of 6278.45%. This contributed to the annual value of $343000.0 for FY2021, which is 5862.48% down from last year.
  • Veracyte's Non-Current Deffered Revenue amounted to $278000.0 in Q1 2022, which was down 6278.45% from $343000.0 recorded in Q4 2021.
  • In the past 5 years, Veracyte's Non-Current Deffered Revenue ranged from a high of $4.1 million in Q1 2018 and a low of $278000.0 during Q1 2022
  • For the 4-year period, Veracyte's Non-Current Deffered Revenue averaged around $1.9 million, with its median value being $788000.0 (2020).
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first tumbled by 635.96% in 2018, then plummeted by 6278.45% in 2022.
  • Veracyte's Non-Current Deffered Revenue (Quarter) stood at $3.9 million in 2018, then crashed by 78.74% to $829000.0 in 2020, then tumbled by 58.62% to $343000.0 in 2021, then fell by 18.95% to $278000.0 in 2022.
  • Its last three reported values are $278000.0 in Q1 2022, $343000.0 for Q4 2021, and $552000.0 during Q3 2021.